ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.44
+0.09 (1.42%)
At close: Apr 2, 2026, 4:00 PM EDT
6.57
+0.13 (2.02%)
After-hours: Apr 2, 2026, 4:45 PM EDT
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $58.26 million as of April 2, 2026. Its market cap has increased by 35.64% in one year.
Market Cap
58.26M
Enterprise Value
67.65M
1-Year Change
35.64%
Ranking
Category
Stock Price
$6.44
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $58.26M, an increase of 2,824.77%. That is a compound annual growth rate of 10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 58.26M | 4.73% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 63.68M |
| Acrivon Therapeutics | 58.89M |
| Actuate Therapeutics | 58.80M |
| Entera Bio | 58.74M |
| OnKure Therapeutics | 58.66M |
| TScan Therapeutics | 57.47M |
| MindWalk Holdings | 56.62M |
| ImageneBio | 55.59M |